Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wayne

Showing results (311-320 of 400) with videos related to

Pageof 40
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agentsD C West, R C Shamberger, R M Macklis, et al.
Blood|February 5, 2010
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphomaKieron Dunleavy, Richard F Little, Stefania Pittaluga, et al.
ACS Chemical Neuroscience|April 21, 2015
In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptorsF Ivy Carroll, Hernán A Navarro, S Wayne Mascarella, et al.
Experimental and Therapeutic Medicine|December 22, 2021
<i>In vitro</i> and <i>in vivo</i> effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemiaYongsheng Ruan, Hye Na Kim, Heather A Ogana, et al.
ACS Chemical Neuroscience|November 21, 2017
Caged Naloxone: Synthesis, Characterization, and Stability of 3- O-(4,5-Dimethoxy-2-nitrophenyl)carboxymethyl Naloxone (CNV-NLX)Anita H Lewin, Scott E Fix, Desong Zhong, et al.
JMIR Serious Games|May 28, 2016
Crave-Out: A Distraction/Motivation Mobile Game to Assist in Smoking CessationKathryn L DeLaughter, Rajani S Sadasivam, Ariana Kamberi, et al.
Journal of Medicinal Chemistry|August 19, 2014
Design, synthesis, and biological evaluation of (3R)-1,2,3,4-tetrahydro-7-hydroxy-N-[(1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl]-3-isoquinolinecarboxamide (JDTic) analogues: in vitro pharmacology and ADME profileChad M Kormos, Moses G Gichinga, Rangan Maitra, et al.
Clinical and Experimental Immunology|February 6, 2010
Infant CD4 C868T polymorphism is associated with increased human immunodeficiency virus (HIV-1) acquisitionR Y Choi, C Farquhar, J Juno, et al.
Journal of Medicinal Chemistry|February 16, 2011
Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotineF Ivy Carroll, Ana Z Muresan, Bruce E Blough, et al.
Bone Marrow Transplantation|March 30, 2004
Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host diseaseM R Robinson, S S Lee, B I Rubin, et al.
Pageof 40

Showing results (311-320 of 400) with videos related to

Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agentsD C West, R C Shamberger, R M Macklis, et al.
Blood|February 5, 2010
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphomaKieron Dunleavy, Richard F Little, Stefania Pittaluga, et al.
ACS Chemical Neuroscience|April 21, 2015
In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptorsF Ivy Carroll, Hernán A Navarro, S Wayne Mascarella, et al.
Experimental and Therapeutic Medicine|December 22, 2021
<i>In vitro</i> and <i>in vivo</i> effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemiaYongsheng Ruan, Hye Na Kim, Heather A Ogana, et al.
ACS Chemical Neuroscience|November 21, 2017
Caged Naloxone: Synthesis, Characterization, and Stability of 3- O-(4,5-Dimethoxy-2-nitrophenyl)carboxymethyl Naloxone (CNV-NLX)Anita H Lewin, Scott E Fix, Desong Zhong, et al.
JMIR Serious Games|May 28, 2016
Crave-Out: A Distraction/Motivation Mobile Game to Assist in Smoking CessationKathryn L DeLaughter, Rajani S Sadasivam, Ariana Kamberi, et al.
Journal of Medicinal Chemistry|August 19, 2014
Design, synthesis, and biological evaluation of (3R)-1,2,3,4-tetrahydro-7-hydroxy-N-[(1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl]-3-isoquinolinecarboxamide (JDTic) analogues: in vitro pharmacology and ADME profileChad M Kormos, Moses G Gichinga, Rangan Maitra, et al.
Clinical and Experimental Immunology|February 6, 2010
Infant CD4 C868T polymorphism is associated with increased human immunodeficiency virus (HIV-1) acquisitionR Y Choi, C Farquhar, J Juno, et al.
Journal of Medicinal Chemistry|February 16, 2011
Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotineF Ivy Carroll, Ana Z Muresan, Bruce E Blough, et al.
Bone Marrow Transplantation|March 30, 2004
Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host diseaseM R Robinson, S S Lee, B I Rubin, et al.
Pageof 40